# FRS3

## Overview
FRS3, or fibroblast growth factor receptor substrate 3, is a gene that encodes an adaptor protein involved in critical cellular signaling pathways. The protein encoded by FRS3 is primarily recognized for its role in mediating signal transduction from receptor tyrosine kinases, such as the fibroblast growth factor receptor (FGFR) and nerve growth factor receptor (NGFR). As an adaptor protein, FRS3 facilitates interactions between these receptors and downstream signaling molecules, playing a pivotal role in cellular processes like proliferation, differentiation, and survival (Avery2007UNC51like; Gotoh2009Feedback). Notably, FRS3 is expressed in neuronal tissues, where it contributes to neuronal differentiation and acts as a negative regulator of epidermal growth factor receptor (EGFR) signaling, maintaining balanced cellular signaling pathways (Zhou2009FGFreceptor; Gotoh2009Feedback). The dysregulation of FRS3 has been implicated in various diseases, including cancer, underscoring its potential as a target for therapeutic intervention (Valencia2011Role).

## Function
FRS3, or fibroblast growth factor receptor substrate 3, is an adaptor protein involved in signal transduction pathways, particularly those initiated by fibroblast growth factors (FGFs). It plays a crucial role in mediating signals from receptor tyrosine kinases, such as the fibroblast growth factor receptor (FGFR) and nerve growth factor receptor (NGFR), through its phosphotyrosine-binding (PTB) domain (Avery2007UNC51like; Gotoh2009Feedback). FRS3 is heavily involved in the FGF signaling pathway, where it contributes to cellular processes like proliferation, differentiation, and survival by facilitating interactions between FGFRs and downstream signaling molecules (Zhou2009FGFreceptor; Avery2007UNC51like).

In neuronal tissues, FRS3 is specifically expressed and plays a significant role in neuronal differentiation, particularly in the context of FGF and EGF signaling pathways (Zhou2009FGFreceptor). It is involved in the activation of ERK signaling, which is crucial for cell differentiation and proliferation (Zhou2009FGFreceptor). FRS3 also acts as a negative regulator of EGF receptor signaling by inhibiting EGFR autophosphorylation, thus maintaining EGFR in an inactive state after ERK activation (Gotoh2009Feedback). This regulatory function highlights its importance in maintaining balanced signaling pathways within cells.

## Clinical Significance
Alterations in the expression or function of the FRS3 gene have been implicated in various diseases, particularly in cancer. In prostate cancer, FRS3, along with FRS2, plays a role in fibroblast growth factor (FGF) signaling, which is crucial for cancer cell proliferation, migration, and invasion. Studies have shown that dual silencing of FRS2 and FRS3 significantly inhibits FGF-induced ERK activation, suggesting that these proteins are important for cancer cell recovery post-radiation therapy. This indicates that targeting FRS3 could be a potential therapeutic strategy in combination with radiation therapy (Valencia2011Role).

In the context of epidermal growth factor receptor (EGFR) signaling, FRS3, also known as SNT-2, acts as a negative regulator. Its downregulation in certain cancer cell lines, such as those derived from brain tumors or lung cancers, suggests that FRS3 expression might be disadvantageous for tumor cell growth or survival. This downregulation could potentially release its inhibitory effect on EGFR signaling, promoting cellular growth and contributing to oncogenesis (Huang2006Unique).

Overall, the dysregulation of FRS3 interactions and expression levels is associated with cancer progression, highlighting its potential as a target for therapeutic intervention.

## Interactions
FRS3, also known as fibroblast growth factor receptor substrate 3, is involved in various protein interactions that play a crucial role in signal transduction pathways. FRS3 interacts with fibroblast growth factor receptors (FGFRs) through its phosphotyrosine binding (PTB) domain, which is essential for mediating downstream signaling events (Avery2007UNC51like). This interaction is similar to the binding of FGFR to the FRS2 PTB domain, highlighting a conserved mechanism across these proteins (Avery2007UNC51like).

FRS3 also forms complexes with other signaling proteins such as Grb2 and Shp2. These interactions are facilitated by specific tyrosine phosphorylation sites on FRS3, which serve as binding sites for these proteins. The Shp2-binding sites on FRS3 are particularly important for its role in eye development, as demonstrated in studies using Xenopus laevis (Kim2015Xenopus).

In addition to its role in FGFR signaling, FRS3 is involved in the negative regulation of the EGF receptor tyrosine kinase signaling pathways. It interacts with ERK2, forming a complex that inhibits ERK activation and subsequently downregulates the EGFR/Ras/ERK signaling cascade (Huang2006Unique). These interactions underscore the multifaceted role of FRS3 in cellular signaling and its potential impact on various physiological processes.


## References


[1. (Avery2007UNC51like) Adam W. Avery, Claudia Figueroa, and Anne B. Vojtek. Unc-51-like kinase regulation of fibroblast growth factor receptor substrate 2/3. Cellular Signalling, 19(1):177–184, January 2007. URL: http://dx.doi.org/10.1016/j.cellsig.2006.06.003, doi:10.1016/j.cellsig.2006.06.003. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2006.06.003)

[2. (Zhou2009FGFreceptor) Wenchao Zhou, Xiujing Feng, Yingjie Wu, Johannes Benge, Zhe Zhang, and Zhengjun Chen. Fgf-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the fgf pathway. Cell Research, 19(10):1165–1177, August 2009. URL: http://dx.doi.org/10.1038/cr.2009.95, doi:10.1038/cr.2009.95. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2009.95)

[3. (Kim2015Xenopus) Yeon-Jin Kim, Minjin Bahn, Yong Hwan Kim, Jee-Yoon Shin, Seon-Woo Cheong, Bong-Gun Ju, Won-Sun Kim, and Chang-Yeol Yeo. Xenopus laevis fgf receptor substrate 3 (xfrs3) is important for eye development and mediates pax6 expression in lens placode through its shp2-binding sites. Developmental Biology, 397(1):129–139, January 2015. URL: http://dx.doi.org/10.1016/j.ydbio.2014.10.019, doi:10.1016/j.ydbio.2014.10.019. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ydbio.2014.10.019)

[4. (Gotoh2009Feedback) Noriko Gotoh. Feedback inhibitors of the epidermal growth factor receptor signaling pathways. The International Journal of Biochemistry &amp; Cell Biology, 41(3):511–515, March 2009. URL: http://dx.doi.org/10.1016/j.biocel.2008.06.019, doi:10.1016/j.biocel.2008.06.019. This article has 20 citations.](https://doi.org/10.1016/j.biocel.2008.06.019)

[5. (Huang2006Unique) L Huang, M Watanabe, M Chikamori, Y Kido, T Yamamoto, M Shibuya, N Gotoh, and N Tsuchida. Unique role of snt-2/frs2β/frs3 docking/adaptor protein for negative regulation in egf receptor tyrosine kinase signaling pathways. Oncogene, 25(49):6457–6466, May 2006. URL: http://dx.doi.org/10.1038/sj.onc.1209656, doi:10.1038/sj.onc.1209656. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1209656)

[6. (Valencia2011Role) Tania Valencia, Ajay Joseph, Naveen Kachroo, Steve Darby, Susan Meakin, and Vincent J Gnanapragasam. Role and expression of frs2 and frs3 in prostate cancer. BMC Cancer, November 2011. URL: http://dx.doi.org/10.1186/1471-2407-11-484, doi:10.1186/1471-2407-11-484. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2407-11-484)